OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues

WOBURN, Mass., December 02, 2024--OSSIO, Inc., a fast-growing medical device company focused on evolving orthopedic surgery with bio-integrative fixation technology, recently closed on $27.6 million in equity funding to rapidly scale all aspects of its commercial efforts, including a new product pip..